Jiangsu Sihuan Bioengineering Co Ltd (000518) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Sihuan Bioengineering Co Ltd (000518) has a cash flow conversion efficiency ratio of 0.104x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.43 Million ≈ $5.92 Million USD) by net assets (CN¥388.58 Million ≈ $56.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 000518 market cap for the company's overall valuation and market capitalisation.
Jiangsu Sihuan Bioengineering Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Jiangsu Sihuan Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jiangsu Sihuan Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Sihuan Bioengineering Co Ltd ranked by their cash flow conversion efficiency. Explore 000518 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Caisse Regionale de Credit Agricole Mutuel Brie Picardie
PA:CRBP2
|
0.133x |
|
Jiangsu Feymer Technology Co Ltd
SHG:688350
|
0.064x |
|
W olf Photoelectric Technology Ltd
SHE:002962
|
0.015x |
|
Shandong Oriental Ocean Sci-Tech Co Ltd
SHE:002086
|
-0.035x |
|
G-Tech Optoelectronics Corp
TW:3149
|
-0.055x |
|
Insteel Industries Inc
NYSE:IIIN
|
-0.002x |
|
Alpha Hpa Ltd
AU:A4N
|
-0.029x |
|
Zhejiang Tiancheng Control Co
SHG:603085
|
0.103x |
Annual Cash Flow Conversion Efficiency for Jiangsu Sihuan Bioengineering Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Sihuan Bioengineering Co Ltd from 1998 to 2024. View latest Jiangsu Sihuan Bioengineering Co Ltd stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥398.97 Million ≈ $58.38 Million |
CN¥1.46 Million ≈ $213.84K |
0.004x | +15.25% |
| 2023-12-31 | CN¥512.78 Million ≈ $75.04 Million |
CN¥1.63 Million ≈ $238.47K |
0.003x | -61.24% |
| 2022-12-31 | CN¥593.50 Million ≈ $86.85 Million |
CN¥4.87 Million ≈ $712.02K |
0.008x | +3306.67% |
| 2021-12-31 | CN¥646.78 Million ≈ $94.64 Million |
CN¥155.65K ≈ $22.78K |
0.000x | -99.84% |
| 2020-12-31 | CN¥685.05 Million ≈ $100.24 Million |
CN¥100.23 Million ≈ $14.67 Million |
0.146x | +64.78% |
| 2019-12-31 | CN¥660.31 Million ≈ $96.62 Million |
CN¥58.63 Million ≈ $8.58 Million |
0.089x | +152.93% |
| 2018-12-31 | CN¥642.80 Million ≈ $94.06 Million |
CN¥22.57 Million ≈ $3.30 Million |
0.035x | +319.88% |
| 2017-12-31 | CN¥675.54 Million ≈ $98.85 Million |
CN¥-10.79 Million ≈ $-1.58 Million |
-0.016x | -184.26% |
| 2016-12-31 | CN¥611.10 Million ≈ $89.42 Million |
CN¥11.58 Million ≈ $1.69 Million |
0.019x | +108.47% |
| 2015-12-31 | CN¥608.69 Million ≈ $89.07 Million |
CN¥-136.11 Million ≈ $-19.92 Million |
-0.224x | -903.20% |
| 2014-12-31 | CN¥721.59 Million ≈ $105.59 Million |
CN¥20.09 Million ≈ $2.94 Million |
0.028x | +207.00% |
| 2013-12-31 | CN¥730.78 Million ≈ $106.94 Million |
CN¥-19.02 Million ≈ $-2.78 Million |
-0.026x | -139.59% |
| 2012-12-31 | CN¥830.24 Million ≈ $121.49 Million |
CN¥54.56 Million ≈ $7.98 Million |
0.066x | +199.90% |
| 2011-12-31 | CN¥915.76 Million ≈ $134.00 Million |
CN¥20.07 Million ≈ $2.94 Million |
0.022x | -91.68% |
| 2010-12-31 | CN¥879.72 Million ≈ $128.73 Million |
CN¥231.62 Million ≈ $33.89 Million |
0.263x | +229.06% |
| 2009-12-31 | CN¥712.38 Million ≈ $104.24 Million |
CN¥57.00 Million ≈ $8.34 Million |
0.080x | -19.30% |
| 2008-12-31 | CN¥692.86 Million ≈ $101.39 Million |
CN¥68.69 Million ≈ $10.05 Million |
0.099x | +207.07% |
| 2007-12-31 | CN¥833.76 Million ≈ $122.01 Million |
CN¥26.92 Million ≈ $3.94 Million |
0.032x | +187.62% |
| 2006-12-31 | CN¥1.01 Billion ≈ $147.97 Million |
CN¥-37.26 Million ≈ $-5.45 Million |
-0.037x | -581.72% |
| 2005-12-31 | CN¥1.00 Billion ≈ $146.76 Million |
CN¥-5.42 Million ≈ $-793.25K |
-0.005x | -111.07% |
| 2004-12-31 | CN¥1.11 Billion ≈ $161.96 Million |
CN¥54.05 Million ≈ $7.91 Million |
0.049x | -35.47% |
| 2003-12-31 | CN¥1.10 Billion ≈ $160.34 Million |
CN¥82.91 Million ≈ $12.13 Million |
0.076x | -53.23% |
| 2002-12-31 | CN¥1.06 Billion ≈ $155.49 Million |
CN¥171.92 Million ≈ $25.16 Million |
0.162x | +441.00% |
| 2001-12-31 | CN¥983.04 Million ≈ $143.85 Million |
CN¥29.40 Million ≈ $4.30 Million |
0.030x | -74.00% |
| 2000-12-31 | CN¥204.83 Million ≈ $29.97 Million |
CN¥23.56 Million ≈ $3.45 Million |
0.115x | +424.44% |
| 1999-12-31 | CN¥156.83 Million ≈ $22.95 Million |
CN¥3.44 Million ≈ $503.34K |
0.022x | +152.29% |
| 1998-12-31 | CN¥104.29 Million ≈ $15.26 Million |
CN¥-4.37 Million ≈ $-640.11K |
-0.042x | -- |
About Jiangsu Sihuan Bioengineering Co Ltd
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded … Read more